These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1825389)

  • 1. Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosis.
    Patrono C; Ciabattoni G; Davì G
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():619-22. PubMed ID: 1825389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombocyte aggregation inhibition].
    Buchwald AB
    Internist (Berl); 1998 Aug; 39(8):870-3. PubMed ID: 9757394
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ibuprofen block the cardioprotective effects of aspirin in dental patients?
    Wynn RL; Cook J
    Gen Dent; 2006; 54(1):6, 8-9. PubMed ID: 16494111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandins and ischemic cardiopathy].
    Balsano F; Davì G; Violi F; Censi C
    G Ital Cardiol; 1992 Dec; 22(12):1427-36. PubMed ID: 1294428
    [No Abstract]   [Full Text] [Related]  

  • 6. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboxane biosynthesis in cardiovascular diseases.
    Patrono C; Ciabattoni G; Davi G
    Stroke; 1990 Dec; 21(12 Suppl):IV130-3. PubMed ID: 2260137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)].
    Katori M
    No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent.
    van Genderen PJ; Prins FJ; Michiels JJ; Schrör K
    Br J Haematol; 1999 Mar; 104(3):438-41. PubMed ID: 10086775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification mechanisms in platelet activation and arterial thrombosis.
    De Clerck FF; Janssen PA
    J Hypertens Suppl; 1990 Dec; 8(7):S87-93. PubMed ID: 2128890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboxane molecules are not hairpin conformers.
    Langs DA; DeTitta GT; Erman MG; Fortier S
    Adv Prostaglandin Thromboxane Res; 1980; 6():477-80. PubMed ID: 7386281
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of thrombosis].
    Tanaka K
    Nihon Rinsho; 1986 May; 44(5):1019-27. PubMed ID: 3528562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombocyte function inhibitors in stroke prevention. Ticlopidine as an alternative to acetylsalicylic acid].
    Busse O
    Fortschr Med; 1994 Sep; 112(27):365-6. PubMed ID: 7988969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Paeonia obovata 801 on metabolism of thromboxane B2 and arachidonic acid and on platelet aggregation in patients with coronary heart disease and cerebral thrombosis].
    Liu J
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):477-81. PubMed ID: 6418338
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of platelet activation in Alzheimer's disease.
    Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
    Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.